Bourhis, J.; Le Tourneau, C.; Calderon, B.; Martin, L.; Sire, C.; Pointreau, Y.; Ramee, J-F.; Coutte, A.; Boisselier, P.; Kaminsky-Forrett, M-C.; Delord, J-P.; Clatot, F.; Sun, X.; Villa, J.; Magne, N.; Eliçin, O; Damstrup, L.; Gollmer, K.; Crompton, P. and Tao, Y. (2022). LBA33 5-year overall survival (OS) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) treated with xevinapant + chemoradiotherapy (CRT) vs placebo + CRT in a randomized, phase II study. Annals of oncology, 33(S7), S1400-S1400. Elsevier 10.1016/j.annonc.2022.08.030
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
1-s2.0-S0923753422039084-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (80kB) | Request a copy |
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Clinic of Radiation Oncology |
UniBE Contributor: |
Eliçin, Olgun |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1569-8041 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Basak Ginsbourger |
Date Deposited: |
01 Dec 2022 12:51 |
Last Modified: |
05 Dec 2022 16:29 |
Publisher DOI: |
10.1016/j.annonc.2022.08.030 |
BORIS DOI: |
10.48350/175384 |
URI: |
https://boris.unibe.ch/id/eprint/175384 |
Actions (login required)
 |
Edit item |